ARCHIVES

Intensity Modulated Therapy Safer Than Three-Dimensional Radiation

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Part One Of A Two-Part Interview With NCI Director Harold Varmus

July 22, 2011

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007

Over $20 Million Carved Out From Statistical, Operations Centers

May 16, 2014

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012